Moxifloxacin vs Trastuzumab
Moxifloxacin vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Moxifloxacin and Trastuzumab.
Mechanism of Action
Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Moxifloxacin β 12 hours; Trastuzumab β 28 days.
Chemical Properties
Molecular Formula: Moxifloxacin β C21H24FN3O4.
Molecular Weight: Moxifloxacin β 401.4350 g/mol.
Type: Moxifloxacin β Small molecule; Trastuzumab β Antibody.